Sunday, August 20, 2017 6:07:52 PM
Followed By The EMA And Japan.
http://www.genengnews.com/gen-news-highlights/pluristem-nybc-win-900k-to-test-plx-r18-cells-alongside-cord-blood-transplants/81253611
http://www.chemdiv.com/pluristem-fukushima-medical-university-evaluate-plx-r18-cells-radiation-treatment/
The parties will evaluate PLX-R18 cells as a potential treatment for radiation-induced damage to lungs, skin and gastrointestinal tract.
The research also includes development of preclinical prototypes of radiation damage in these tissues for use in clinical trials.
As part of the research, Pluristem will offer PLX-R18 cells and scientific know-how. Fukushima Medical University will carry out studies and supply the required resources.
The partnership will be conducted concurrently with a research being funded by the US National Institutes of Health (NIH), which is examining PLX-R18 cells as a potential treatment for hematologic component of ARS.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM